Drug Database
Back to search

Sweden· SE-20100302000013

Mifepristone Nordic 200 mg Tablett

A mifepristone product containing mifepristone, registered in Sweden by Nordic Group BV. The same ATC class is registered in 14 of our 19 countries.

ATC G03XB01

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedMifepristone Nordic 200 mg TablettATCG03XB01REGISTER NO.SE-20100302000013PACKS LISTED1CHECKEDOctober 1, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mifepristoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mifepristone is registered in 14 of 19 countries.

Countries holding a registration under ATC G03XB01 (mifepristone), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 8 of them publish a price we can compare per daily dose
Search mifepristone products by name

Mifepristone · ATC G03XB01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mifepristone costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mifepristone · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$53.60
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Mifepristone
Manufacturer
Nordic Group BV
Country
Sweden (SE)
ATC code
G03XB01
ATC class
Mifepristone
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20100302000013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for mifepristone.

Graded by severity as the source publishes them — 209 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mifepristone against other medicinesHow interaction checks work

Mifepristone · interactions on record

378 records

  • 209 severe
  • 161 moderate
  • 8 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mifepristone in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mifepristone products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Mifegyne
  • Belgium · Mifegyne
  • Bulgaria · Мифегин
  • Cyprus · Mifegyne
  • Czechia · Mifegyne
  • Germany · Mifegyne
  • Denmark · Mifegyne
  • Estonia · Mifegyne
  • Spain · Mifegyne
  • Finland · Mifegyne
  • France · Mifegyne, Miffee
  • United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
  • Greece · Mifegyne
  • Croatia · Mifegyne
  • Ireland · Mifegyne
  • Iceland · Mifegyne
  • Italy · Mifegyne
  • Lithuania · Mifegyne
  • Luxembourg · Mifegyne
  • Latvia · Mifegyne
  • Netherlands · Mifegyne
  • Norway · Mifegyne
  • Portugal · Mifegyne
  • Romania · Mifegyne
  • Slovenia · Mifegyne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cbffda93-ba0f-45a3-9659-7331dba0e1f8
GET /v1/drugs/cbffda93-ba0f-45a3-9659-7331dba0e1f8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "sPAR",
    "PAR",
    "SmPC"
  ],
  "se_npl_id": "20100302000013",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20100302000013",
  "product_doc_link": "https://docetp.mpa.se/LMF/Mifepristone%20Nordic%20tablet%20ENG%20SmPC_09001bee84f9df97.pdf"
}
API referenceMCP serverPlans

See everything about mifepristone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console